1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Molecular Diagnostics: An Insight to Rising Markets and Trends in Cancer and Prenatal Technologies - Overview

Molecular Diagnostics: An Insight to Rising Markets and Trends in Cancer and Prenatal Technologies covers market research, relevant disease background, and a number of rising technologies available to physicians and clinicians in the cancer and prenatal space. This report focuses on market background of the areas that are covered, including lung, breast, thyroid and blood cancers (specifically leukemia and lymphoma), as well as pre-conception genetic information and prenatal diagnostics.

Included in this Report:

Cancer diagnostics companies interviewed include: GeneCentric, Veracyte, Adaptive Biotechnologies
Genetic and prenatal diagnostics research companies including GenePeeks and Verinata Health
Comprehensive coverage of survey results (n=123) from the various companies and researchers working in molecular diagnostics.
A company directory which was created for this report. This includes several seasoned and emerging companies, their areas of focus, and the status of their technologies.

Table Of Contents

Molecular Diagnostics: An Insight to Rising Markets and Trends in Cancer and Prenatal Technologies - Overview
Executive Summary

PART I: Introduction and Market Background

CHAPTER 1: The Focus of This Report

CHAPTER 2: Market Trends and Adaptability

Lung cancer diagnostics market growth
Breast cancer diagnostics market growth
Thyroid cancer diagnostics market growth
Blood cancer diagnostics market growth
Prenatal diagnostics market growth
PART II: Cancer Diagnostics

CHAPTER 3: Lung Cancer

Types of lung cancer
Risk factors
Incidence
Symptoms and early detection
Targeted therapies
CHAPTER 4: Breast Cancer

Types of breast cancer
Risk factors
Incidence
Symptoms and early detection
Treatments for breast cancer
CHAPTER 5: GeneCentric

Company background
Lung Subtype Platform (LSP)
Hypoxia Signature Platform
GeneCentric outlook
Interview with Myla Lai-Goldman
Company background
Platforms
Future outlook
CHAPTER 6: Thyroid Cancer

Types
Risk
Symptoms and early detection
Therapeutic options
CHAPTER 7: Veracyte

Company background
Afirma Thyroid FNA Analysis
Validation
Competitive advantage
Future growth plans
Interview with Bonnie Anderson
Company background
Afirma Thyroid FNA Analysis
Competitive advantage
Challenges encountered
Future improvements
CHAPTER 8: Blood-Based Cancers

Leukemia
Types
Risk factors, symptoms and early detection
Therapeutic options
Lymphoma
Types
Classic Hodgkin disease
Nodular lymphocyte predominant Hodgkin disease
Non-Hodgkin lymphoma
Risk factors
Symptoms and therapeutic options
CHAPTER 9: Adaptive Biotechnologies Corporation

Company background
ClonoSEQ
Validation
Areas of improvement
Competitive advantage
Future endeavors
Interview with Chad Robins
Company background
ClonoSEQ
Areas of improvement
Challenges encountered
Competitive advantage
Future endeavors
PART III: Genetic Information and Prenatal Diagnostics

CHAPTER 10: Genetic Information and Prenatal Testing

Genetic information
Prenatal testing
Sequence-based cell-free DNA testing
Fetal cell isolation
CHAPTER 11: GenePeeks

Company background
Patented technology
How does the process work?
Validation
Accuracy and sensitivity
Areas of improvement
Competitive advantage
Future applications
Interview with Anne Morriss
Company background
Patented technology
Competitive advantage
Areas of improvement and future outlook
CHAPTER 12: Verinata Health

Company background
The verifi® prenatal test
Clinical validation and reimbursement
Customer feedback
CHAPTER 13: Testing Specifications

PART IV: Survey Demographics

CHAPTER 14: Survey Results

Survey demographics
Areas of study
Rising technologies
Challenges encountered
PART V: Company Directory

References

About Cambridge Healthtech Institute

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Human Epidermal growth factor Receptor type 2 (HER2-) breast cancer is the second ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

  • $ 5995
  • Industry report
  • December 2016
  • by GlobalData

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts Summary Companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows ...


Download Unlimited Documents from Trusted Public Sources

Hospital Statistics in the US

  • March 2017
    16 pages
  • Hospital  

    Breast Cancer  

  • United States  

View report >

OTC Markets in the US

  • March 2017
    10 pages
  • Pancreatic Canc...  

    Vitamin  

  • United States  

View report >

Cancer and Colorectal Cancer Statistics in the UK - Forecast

  • March 2017
    91 pages
  • Cancer  

    Colorectal Canc...  

    Health Care Pro...  

  • United Kingdom  

View report >

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.